Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma
Allergy · 2026
DOI: 10.1111/all.70292 ↗At a glance
Journal article in Allergy, 2026. Written by Maria Gluud and 23 co-authors. Institution: Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark. Major MEDLINE topics: Lymphoma, T-Cell, Cutaneous, Staphylococcus aureus, T-Lymphocytes, Lymphocyte Activation. Cited 7 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: LEO Fondet, Dr. Abildgaard Fellowship, Danish Council for Independent Research.
Abstract (original language)
Background
Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma (CTCL) shares clinical similarities with AD and is also associated with a high prevalence of Staphylococcus aureus ( S. aureus ) colonisation. However, the mechanisms driving skin barrier damage in CTCL and the contribution of bacteria remain poorly understood.
Methods
We investigate how the interplay between S. aureus (and staphylococcal enterotoxins (SEs)) and primary malignant‐ and non‐malignant T cells affects keratinocyte expression of skin barrier proteins; in vitro, in an EL4 murine lymphoma model of bacteria‐driven tumour progression, and in CTCL patient lesions colonised with SE‐producing S. aureus before and after bacterial eradication by antibiotic treatment.
Results
S. aureus and SEs activate malignant and non‐malignant T cells to release barrier‐repressing cytokines, including IL‐4, IL‐13, IL‐22, and OSM, and JAK‐dependent downregulation of filaggrin and loricrin in keratinocytes. In the EL4 model, bacteria‐colonised tumour‐bearing mice show significant filaggrin loss in tumour‐adjacent epidermis, whereas antibiotic‐treated mice maintain near‐normal expression. Clinically, antibiotic eradication of SE‐producing S. aureus partially restores filaggrin and loricrin expression in three of four patients, paralleling reduced inflammatory signalling.
Conclusions
SE‐producing S. aureus promotes skin barrier impairment in CTCL through cytokine‐driven, JAK‐dependent repression of structural proteins in keratinocytes. These findings identify microbial–immune crosstalk as a contributor to CTCL skin pathology and provide mechanistic rationale for strategies targeting S. aureus colonisation as adjunctive therapy in CTCL.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark.
- Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Dermatology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
- Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
ORCID profiles: Maria Gluud, Emil M Pallesen, Ziao Zeng, Martin R J Namini, Chella Krishna Vadivel, Lise Mette Rahbek Gjerdrum, Lang Yan, Sana Ahmad, Lise M Lindahl, Michael Bzorek, Maria R Kamstrup, Saptaswa Dey, Sisse Rye Ostrowski, Erik Sørensen, Pia Rantakari, Charlotte Menne Bonefeld, Carsten Geisler, Anders Woetmann, Riitta Lahesmaa, Lars Iversen, Peter Wolf, Thomas Litman, Terkild B Buus, Niels Ødum
Funding
- LEO Fondet
- Dr. Abildgaard Fellowship
- Danish Council for Independent Research
- Research Council of Finland
- Kræftens Bekæmpelse
- Novo Nordisk Fonden
- The Sigrid Jusélius Foundation
- Danmarks Frie Forskningsfond
Cite
APA
Gluud, M., Pallesen, E. M., Zeng, Z., Namini, M. R. J., Vadivel, C. K., Gjerdrum, L. M. R., Yan, L., Ahmad, S., Lindahl, L. M., Bzorek, M., Kamstrup, M. R., Dey, S., Ostrowski, S. R., Sørensen, E., Rantakari, P., Bonefeld, C. M., Geisler, C., Woetmann, A., Lahesmaa, R., …, & Ødum, N. (2026). Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma. Allergy. https://doi.org/10.1111/all.70292
Vancouver
Gluud M, Pallesen EM, Zeng Z, Namini MRJ, Vadivel CK, Gjerdrum LMR, et al. Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma. Allergy. 2026. doi:10.1111/all.70292
BibTeX
@article{Gluud2026,
author = {Gluud, Maria and Pallesen, Emil M and Zeng, Ziao and Namini, Martin R J and Vadivel, Chella Krishna and Gjerdrum, Lise Mette Rahbek and Yan, Lang and Ahmad, Sana and Lindahl, Lise M and Bzorek, Michael and Kamstrup, Maria R and Dey, Saptaswa and Ostrowski, Sisse Rye and Sørensen, Erik and Rantakari, Pia and Bonefeld, Charlotte Menne and Geisler, Carsten and Woetmann, Anders and Lahesmaa, Riitta and Iversen, Lars and Wolf, Peter and Litman, Thomas and Buus, Terkild B and Ødum, Niels},
title = {Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma},
journal = {Allergy},
year = {2026},
doi = {10.1111/all.70292}
}
EUVIMED